2Little E G, Eide M J. Update on the current state of melanomaincidence [J]. Dermatol Clin, 2012, 30(3):355-361. 被引量：1
3Hsieh R, Firmiana A, Sotto M N, et al. Expression of 16 proteins in acral lentiginous melanoma [J].Int J Dermatol, 2009, 48(12) : 1303-1307. 被引量：1
4Ascierto P A, Gogas H J, Grob J J, et al. Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert review [J]. Crit Rev Oncol Hematol, 2013, 85(2):149-161. 被引量：1
5Fan M, Pfeffer S R, Lynch H T, et al. Altered tanscriptome signature of phenotypieally normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention [J]. Oncotarget, 2013, 4(1) : 128-141. 被引量：1
6Davar D, Tarhini A A, Kirkwood J M, et al. Adjuvant therapy for melanoma [J]. Cancer, 2012, 18(2) : 192-202. 被引量：1
7Tate D J, Patterson J R, Velasco-Gonzalez C, et al. Interferon- Gamma-Induced Nitric Oxide inhibits the proliferation of murine renal cell carcinoma cells [J]. Int J Biol Sci, 2012, 8 (8) : 1109-1120. 被引量：1
8Li P, Du Q, Cao Z, et al. Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular regulatory factor-1 (IRF-1) 213-222. (HCC) cells through interferon- [J]. Cancer Lett, 2012, 314(2):213-222. 被引量：1
